MARSIGLIA, MATTEO DOMENICO

Nome completo

Afferenza

Dipartimento di Scienze della Salute

Mostra records

Risultati 1 - 5 di 5 (tempo di esecuzione: 0.0 secondi).

The Emerging Role of Gut Microbiota in Inflammatory Skin Diseases: A Systematic Review

2026 A. Malgesini, M.D. Marsiglia, E. Borghi, A.V. Marzano, G. Nazzaro

Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study

2025 M. Tosi, M.D. Marsiglia, E. Ottaviano, S. Parolisi, J. Zuvadelli, S. Ancona, C. Ceccarani, M. Teresa Carbone, G. Cefalo, E. Borghi, E. Verduci

Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial

2025 F. Triva, E. Borghi, M.D. Marsiglia, E. Ottaviano, E. Ricci, P. Tognini, M. Montecucco, A. Vignoli

Tuberous sclerosis complex, epilepsy, and the microbiota-gut-brain axis: a pilot study of shared and divergent microbial signatures

2025 E. Ottaviano, M.D. Marsiglia, C. Ceccarani, S. Ancona, F. Triva, F. La Briola, S. Bergamoni, F. Teutonico, A. Pompili, I. Viganò, E. Ricci, A. Vignoli, E. Borghi

Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients

2025 M.D. Marsiglia, S. Bianchi, F. Bai, C. Tincati, E. Ottaviano, S. Ancona, G. Marchetti, E. Borghi

Titolo	Data di pubblicazione	Autori	Tipo	Abstract
The Emerging Role of Gut Microbiota in Inflammatory Skin Diseases: A Systematic Review	2026	Malgesini, AndreaMarsiglia, Matteo DomenicoBorghi, ElisaMarzano, Angelo VNazzaro, Gianluca	Article (author)	-
Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study	2025	Martina TosiMatteo Domenico MarsigliaEmerenziana OttavianoSara ParolisiJuri ZuvadelliSilvia AnconaCamilla CeccaraniMaria Teresa CarboneGraziella CefaloElisa BorghiElvira Verduci + -	Article (author)	-
Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial	2025	Triva, FrancescaBorghi, ElisaMarsiglia, Matteo DomenicoOttaviano, EmerenzianaRicci, EmiliaTognini, PaolaMontecucco, MarcoVignoli, Aglaia + -	Article (author)	-
Tuberous sclerosis complex, epilepsy, and the microbiota-gut-brain axis: a pilot study of shared and divergent microbial signatures	2025	Ottaviano, EmerenzianaMarsiglia, Matteo DomenicoCeccarani, CamillaAncona, SilviaTriva, FrancescaLa Briola, FrancescaBergamoni, StefaniaTeutonico, FedericaPompili, AliceViganò, IlariaRicci, EmiliaVignoli, AglaiaBorghi, Elisa + -	Article (author)	-
Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients	2025	Marsiglia, Matteo DomenicoBianchi, SilviaBai, FrancescaTincati, CamillaOttaviano, EmerenzianaAncona, SilviaMarchetti, GiuliaBorghi, Elisa	Article (author)	-

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MARSIGLIA, MATTEO DOMENICO

The Emerging Role of Gut Microbiota in Inflammatory Skin Diseases: A Systematic Review

Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study

Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial

Tuberous sclerosis complex, epilepsy, and the microbiota-gut-brain axis: a pilot study of shared and divergent microbial signatures

Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients